471 related articles for article (PubMed ID: 23161826)
1. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.
Berryer MH; Hamdan FF; Klitten LL; Møller RS; Carmant L; Schwartzentruber J; Patry L; Dobrzeniecka S; Rochefort D; Neugnot-Cerioli M; Lacaille JC; Niu Z; Eng CM; Yang Y; Palardy S; Belhumeur C; Rouleau GA; Tommerup N; Immken L; Beauchamp MH; Patel GS; Majewski J; Tarnopolsky MA; Scheffzek K; Hjalgrim H; Michaud JL; Di Cristo G
Hum Mutat; 2013 Feb; 34(2):385-94. PubMed ID: 23161826
[TBL] [Abstract][Full Text] [Related]
2. De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism.
Hamdan FF; Daoud H; Piton A; Gauthier J; Dobrzeniecka S; Krebs MO; Joober R; Lacaille JC; Nadeau A; Milunsky JM; Wang Z; Carmant L; Mottron L; Beauchamp MH; Rouleau GA; Michaud JL
Biol Psychiatry; 2011 May; 69(9):898-901. PubMed ID: 21237447
[TBL] [Abstract][Full Text] [Related]
3. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
Parker MJ; Fryer AE; Shears DJ; Lachlan KL; McKee SA; Magee AC; Mohammed S; Vasudevan PC; Park SM; Benoit V; Lederer D; Maystadt I; Study D; FitzPatrick DR
Am J Med Genet A; 2015 Oct; 167A(10):2231-7. PubMed ID: 26079862
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism.
Wiltrout K; Brimble E; Poduri A
Epilepsia; 2024 May; 65(5):1428-1438. PubMed ID: 38470175
[TBL] [Abstract][Full Text] [Related]
5. A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA).
Klitten LL; Møller RS; Nikanorova M; Silahtaroglu A; Hjalgrim H; Tommerup N
Epilepsia; 2011 Dec; 52(12):e190-3. PubMed ID: 22050443
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.
Prchalova D; Havlovicova M; Sterbova K; Stranecky V; Hancarova M; Sedlacek Z
BMC Med Genet; 2017 Jun; 18(1):62. PubMed ID: 28576131
[TBL] [Abstract][Full Text] [Related]
7. Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly.
Aceti M; Creson TK; Vaissiere T; Rojas C; Huang WC; Wang YX; Petralia RS; Page DT; Miller CA; Rumbaugh G
Biol Psychiatry; 2015 May; 77(9):805-15. PubMed ID: 25444158
[TBL] [Abstract][Full Text] [Related]
8. Identification of an individual with a SYGNAP1 pathogenic mutation in India.
Verma V; Mandora A; Botre A; Clement JP
Mol Biol Rep; 2020 Nov; 47(11):9225-9234. PubMed ID: 33090308
[TBL] [Abstract][Full Text] [Related]
9. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
10. Multi-parametric analysis of 57 SYNGAP1 variants reveal impacts on GTPase signaling, localization, and protein stability.
Meili F; Wei WJ; Sin WC; Meyers WM; Dascalu I; Callaghan DB; Rogic S; Pavlidis P; Haas K
Am J Hum Genet; 2021 Jan; 108(1):148-162. PubMed ID: 33308442
[TBL] [Abstract][Full Text] [Related]
11. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation.
Hamdan FF; Gauthier J; Spiegelman D; Noreau A; Yang Y; Pellerin S; Dobrzeniecka S; Côté M; Perreau-Linck E; Carmant L; D'Anjou G; Fombonne E; Addington AM; Rapoport JL; Delisi LE; Krebs MO; Mouaffak F; Joober R; Mottron L; Drapeau P; Marineau C; Lafrenière RG; Lacaille JC; Rouleau GA; Michaud JL;
N Engl J Med; 2009 Feb; 360(6):599-605. PubMed ID: 19196676
[TBL] [Abstract][Full Text] [Related]
12. SYNGAP1 mutations: Clinical, genetic, and pathophysiological features.
Agarwal M; Johnston MV; Stafstrom CE
Int J Dev Neurosci; 2019 Nov; 78():65-76. PubMed ID: 31454529
[TBL] [Abstract][Full Text] [Related]
13. SYNGAP1 Mutation in Focal and Generalized Epilepsy: A Literature Overview and A Case Report with Special Aspects of the EEG.
von Stülpnagel C; Funke C; Haberl C; Hörtnagel K; Jüngling J; Weber YG; Staudt M; Kluger G
Neuropediatrics; 2015 Aug; 46(4):287-91. PubMed ID: 26110312
[TBL] [Abstract][Full Text] [Related]
14. The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators.
Weldon M; Kilinc M; Lloyd Holder J; Rumbaugh G
J Neurodev Disord; 2018 Feb; 10(1):6. PubMed ID: 29402231
[TBL] [Abstract][Full Text] [Related]
15. Novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms.
Kimura Y; Akahira-Azuma M; Harada N; Enomoto Y; Tsurusaki Y; Kurosawa K
Congenit Anom (Kyoto); 2018 Nov; 58(6):188-190. PubMed ID: 29381230
[TBL] [Abstract][Full Text] [Related]
16. Molecular and phenotypical findings of a novel de novo SYNGAP1 gene variant in an 11-year-old Iranian boy with intellectual disability.
Mir A; Song Y; Lee H; Nadeali Z; Akbarian F; Tabatabaiefar MA
Lab Med; 2024 Mar; 55(2):204-208. PubMed ID: 37467311
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression.
Jimenez-Gomez A; Niu S; Andujar-Perez F; McQuade EA; Balasa A; Huss D; Coorg R; Quach M; Vinson S; Risen S; Holder JL
J Neurodev Disord; 2019 Aug; 11(1):18. PubMed ID: 31395010
[TBL] [Abstract][Full Text] [Related]
19. Dual Molecular Effects of Dominant RORA Mutations Cause Two Variants of Syndromic Intellectual Disability with Either Autism or Cerebellar Ataxia.
Guissart C; Latypova X; Rollier P; Khan TN; Stamberger H; McWalter K; Cho MT; Kjaergaard S; Weckhuysen S; Lesca G; Besnard T; Õunap K; Schema L; Chiocchetti AG; McDonald M; de Bellescize J; Vincent M; Van Esch H; Sattler S; Forghani I; Thiffault I; Freitag CM; Barbouth DS; Cadieux-Dion M; Willaert R; Guillen Sacoto MJ; Safina NP; Dubourg C; Grote L; Carré W; Saunders C; Pajusalu S; Farrow E; Boland A; Karlowicz DH; Deleuze JF; Wojcik MH; Pressman R; Isidor B; Vogels A; Van Paesschen W; Al-Gazali L; Al Shamsi AM; Claustres M; Pujol A; Sanders SJ; Rivier F; Leboucq N; Cogné B; Sasorith S; Sanlaville D; Retterer K; Odent S; Katsanis N; Bézieau S; Koenig M; Davis EE; Pasquier L; Küry S
Am J Hum Genet; 2018 May; 102(5):744-759. PubMed ID: 29656859
[TBL] [Abstract][Full Text] [Related]
20. De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy.
Nakajima J; Okamoto N; Tohyama J; Kato M; Arai H; Funahashi O; Tsurusaki Y; Nakashima M; Kawashima H; Saitsu H; Matsumoto N; Miyake N
Clin Genet; 2015 Apr; 87(4):356-61. PubMed ID: 24697219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
